<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
  <channel>
    <title>PuSH - HMGU Publikationen</title>
    <link>https://push-zb.helmholtz-munich.de</link>
    <description>
    PuSH - Publikationen-Server des Helmholtz Zentrums München
    </description>
    <language>de-de</language>

    <item>
      <title><![CDATA[Zimdahl, H.* et al. Influence of common polymorphisms in the SLC5A2 gene on metabolic traits in subjects at increased risk of diabetes and on response to empagliflozin treatment in patients with diabetes. Pharmacogenet. Genomics 27, 135-142 (2017)]]></title>
      <description><![CDATA[]]></description>
      <link>https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=50996&amp;la=de</link>
      <guid>https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=50996&amp;la=de</guid>
      <pubDate>Wed, 21 Jun 2017 00:00:00 +0000</pubDate>
    </item>
    
    <item>
      <title><![CDATA[Wjst, M. &amp; Werner, M.* Methods of genotyping. In:. 2016. 21-33 (Pharmacogenet. Genomics)]]></title>
      <description><![CDATA[]]></description>
      <link>https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=64089&amp;la=de</link>
      <guid>https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=64089&amp;la=de</guid>
      <pubDate>Tue, 08 Mar 2022 00:00:00 +0000</pubDate>
    </item>
    
    <item>
      <title><![CDATA[Breitling, L.P.* et al. Variants in COMT and spontaneous smoking cessation: Retrospective cohort analysis of 925 cessation events. Pharmacogenet. Genomics 19, 657-659 (2009)]]></title>
      <description><![CDATA[]]></description>
      <link>https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=1664&amp;la=de</link>
      <guid>https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=1664&amp;la=de</guid>
      <pubDate>Mon, 07 Dec 2009 00:00:00 +0000</pubDate>
    </item>
    
    <item>
      <title><![CDATA[Jaremko, M.* et al. Polymorphism of the DNA repair enzyme XRCC1 is associated with treatment prediction in anthracycline and cyclophosphamide/methotrexate/5-fluorouracil-based chemotherapy of patients with primary invasive breast cancer. Pharmacogenet. Genomics 17, 529-538 (2007)]]></title>
      <description><![CDATA[]]></description>
      <link>https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=4586&amp;la=de</link>
      <guid>https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=4586&amp;la=de</guid>
      <pubDate>Thu, 11 Oct 2007 00:00:00 +0000</pubDate>
    </item>
    </channel>
</rss>